|  | n(%) | P-Value | ||
---|---|---|---|---|---|
Negative (n=65) | Low (n=19) | High (n=5) | |||
Menopausal Status | Pre Menopausal | 13 (20) | 4 (21.1) | 0 (0) | 0.792 |
Post Menopausal | 52 (80) | 15 (78.9) | 5 (100) | ||
Histological Type | endometroid | 60 (92.3) | 14 (73.7) | 3 (60) | 0.009 |
serous | 3 (4.6) | 4 (21.1) | 0 (0) | ||
clear cell | 1 (1.5) | 0 (0) | 0 (0) | ||
carcinosarcoma | 1 (1.5) | 1 (5.3) | 2 (40) | ||
Grade | Grade I | 28 (43.1) | 6 (31.6) | 1 (20) | 0.055 |
Grade II | 30 (46.2) | 6 (31.6) | 2 (40) | ||
Grade III | 7 (10.8) | 7 (36.8) | 2 (40) | ||
Myometial Invasion | Limited To Endometrium | 6 (9.2) | 0 (0) | 0 (0) | 0.753 |
<1/2 Of Myometrium | 23 (35.4) | 6 (31.6) | 2 (40) | ||
>1/2 Of Myometrium | 36 (55.4) | 13 (68.4) | 3 (60) | ||
Cervical Invasion | Present | 15 (23.1) | 6 (31.6) | 2 (40) | 0.524 |
Absent | 50 (76.9) | 13 (68.4) | 3 (60) | ||
Nodal Status | N0 | 61 (93.8) | 18 (94.7) | 5 (100) | 1.000 |
N1 | 3 (4.6) | 1 (5.3) | 0 (0) | ||
N2 | 1 (1.5) | 0 (0) | 0 (0) | ||
Lymphovascular Invasion | Present | 3 (4.6) | 3 (15.8) | 0 (0) | 0.278 |
Absent | 62 (95.4) | 16 (84.2) | 5 (100) | ||
T Stage | T1 | 47 (72.3) | 13 (68.4) | 62 (69.7) | 0.094 |
T2 | 12 (18.5) | 2 (10.5) | 16 (18) | ||
T3 | 4 (6.2) | 4 (21.1) | 8 (9) | ||
T4 | 2 (3.1) | 0 (0) | 3 (3.4) | ||
FIGO Stage | Stage IA | 26 (40) | 6 (31.6) | 2 (40) | 0.155 |
Stage IB | 20 (30.8) | 7 (36.8) | 0 (0) | ||
Stage II | 13 (20) | 2 (10.5) | 2 (40) | ||
Stage IIIA | 4 (6.2) | 3 (15.8) | 0 (0) | ||
Stage IIIB | 0 (0) | 1 (5.3) | 0 (0) | ||
Stage IV | 2 (3.1) | 0 (0) | 1 (20) | ||
Adnexal involvement | Present | 5 (7.7) | 3 (15.8) | 1 (20) | 0.321 |
Absent | 60 (92.3) | 16 (84.2) | 4 (80) |